54.2 % , 11.6 % and 7.4 % of patients first responded with a 50 % reduction in cumulative hours of headache , and 56.3 % , 14.5 % and 7.7 % of patients first responded with a 5-point improvement in total HIT-6 during treatment cycles 1 , 2 and 3 , respectively .